Skip to main content
Granules India Ltd. logo

Granules India Ltd. — Investor Relations & Filings

Ticker · GRANULES ISIN · INE101D01020 LEI · 335800HJF1KE335ASX37 BSE.NS Manufacturing
Open in API
Filings indexed 954 across all filing types
Latest filing 2026-01-08 Call Transcript
Country IN India
Listing BSE.NS GRANULES

About Granules India Ltd.

https://granulesindia.com/

Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an announcement for an upcoming earnings call for Granules India Limited, specifying the date, time, participants, and access details. It does not contain actual financial results or detailed financial data but serves as an invitation or notice for the call. Therefore, it is best classified as a Call Transcript (CT) type document, specifically the announcement or invitation to the earnings call rather than the transcript itself. Given the nature and content, the confidence is high but not absolute since the transcript itself is not included.
2026-01-08 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release dated January 8, 2026, announcing that Granules Pharmaceuticals, Inc., a subsidiary of Granules India Limited, has received FDA Tentative Approval with 180-day exclusivity for a generic Amphetamine Extended-Release Tablets product. The content focuses on regulatory approval news and market potential, with no financial statements, detailed financial analysis, or comprehensive report data. It is a corporate announcement intended for dissemination to stock exchanges and investors. The document length is 7,415 characters, which is relatively short and typical for a press release. There is no indication that this is a full financial report, earnings release, or management discussion. It is not a regulatory filing in the sense of compliance documents or certifications, nor is it a report publication announcement. The nature of the document fits best with a Capital/Financing Update (CAP) category, as it relates to a significant regulatory milestone impacting the company's product portfolio and potential revenue streams, which is a form of capital/market update. Therefore, the appropriate classification is CAP with high confidence.
2026-01-08 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a notice dated January 2, 2026, addressed to stock exchanges regarding a newspaper advertisement about an Extraordinary General Meeting (EGM) and e-voting information. It includes copies of public notices related to auctions and possession notices under the SARFAESI Act for recovery of loans by financial institutions. The content primarily consists of legal and regulatory announcements about loan defaults, auction sales, and possession of properties, not financial results, management changes, or shareholder voting results. There is no indication of a full financial report, earnings release, or management discussion. The document is a regulatory announcement informing the public and stakeholders about legal and enforcement actions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-01-02 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice dated December 31, 2025, announcing an Extraordinary General Meeting (EGM) scheduled for January 22, 2026. The notice includes detailed information about the agenda items, specifically the issuance of convertible warrants and equity shares on a preferential basis. It contains resolutions to be passed by shareholders and procedural details about voting and the meeting format. The document is not a report of financial results, audit, or management discussion, but rather a formal announcement and invitation to shareholders to vote on specific corporate actions. It does not contain financial statements or analysis but is a notice of a shareholder meeting with proposed resolutions. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI) or Notice of Meeting. Given the detailed nature of the notice and the inclusion of explanatory statements for shareholder voting, the best classification is Proxy Solicitation & Information Statement (PSI).
2025-12-31 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window in compliance with SEBI regulations related to insider trading. It mentions the period of closure around the announcement of unaudited financial results but does not contain any financial data, results, or detailed report. The document is an announcement related to regulatory compliance and trading restrictions, not a financial report or earnings release. Given its brief nature and regulatory context, it fits best under Regulatory Filings (RNS).
2025-12-26 English
Outcome of Board Meeting
Regulatory Filings
2025-12-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.